#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pleural mesothelioma malignant Juvenile psoriatic arthritis Head and neck cancer Gastric cancer Anti-myelin-associated glycoprotein associated polyneuropathy Chronic inflammatory demyelinating polyradiculoneuropathy Multiple system atrophy Choroidal dystrophy ROHHAD syndrome Partial lipodystrophy Colitis ulcerative Brain injury Hodgkin's disease recurrent Acute myeloid leukaemia recurrent Hereditary neuropathic amyloidosis More trials…

    Learn about Rare Diseases

    Leiomyosarcoma recurrent – Life with Disease Gastrointestinal stromal tumour – Life with Disease Nephrotic syndrome Uterine leiomyosarcoma – Life with Disease Small intestine leiomyosarcoma – Diagnostics Fabry’s disease – Diagnostics Nodal marginal zone B-cell lymphoma – Life with Disease Ornithine transcarbamoylase deficiency – Diagnostics Antisynthetase syndrome – Life with Disease Wiskott-Aldrich syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Clonazepam Nido-361 SP16 Lib-01 Monohydrate Gozetotide Adrc001 Iti-1284 Pimavanserin Tartrate Cimetidine Jnj-64042056 GSKVX000000070248 GSKVX000000017986 Lisaftoclax Benzyl Alcohol XMAB942 Gen1047 Cefoxitin Sodium Sacubitril Bi 1015550 Blu-263 Phosphate More therapies…

    Learn about Your Condition

    Hepatic cancer Intracranial aneurysm Laryngeal cancer stage I Dedifferentiated liposarcoma Prostate cancer metastatic Adenosquamous cell lung cancer Cytomegalovirus infection Procedural anxiety Fibrosarcoma Thyroid disorder Gastrointestinal disorder Hepatic fibrosis Lymphocytic lymphoma Craniopharyngioma Childhood asthma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cardiac failure

  • Study on the Effects of Sacubitril and Valsartan in Patients with Heart Failure and Mitral Valve Regurgitation

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Mitral valve incompetence
    • Cardiac failure
    • Heart failure with preserved ejection fraction
    Investigated Drugs:
    • Sacubitril
    • Valsartan
    Belgium

  • Study of LY3540378 for Adults with Worsening Chronic Heart Failure with Preserved Ejection Fraction

    Not recruiting

    2 1
    Investigated Drugs:
    • Igg Against Serum Albumin Fused With Relaxin 2, Chain B (2-29) And Relaxin 2 (Chain A)
    Czechia Hungary Poland Spain

  • Study on Stopping Medication in Heart Failure Patients with Cardiac Resynchronization Therapy Using Eplerenone, Valsartan, and Bisoprolol Fumarate

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Bisoprolol Fumarate
    • Eplerenone
    • Furosemide
    Spain

  • Study of AZD3427 for Patients with Heart Failure and Pulmonary Hypertension from Left Heart Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Cardiac failure
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Azd3427
    Austria Czechia Denmark Germany Italy The Netherlands +3

  • Study on Digoxin for Reducing Heart Failure Hospitalizations and Mortality in Outpatients with Chronic Heart Failure

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Digoxin
    The Netherlands

  • Study on the Effects of CDR132L in Patients with Reduced Heart Function After a Heart Attack

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Left ventricular failure
    • Cardiac failure acute
    • Cardiac failure chronic
    Investigated Drugs:
    • Cdr132L
    • Cdr132L Sodium
    Czechia Germany Greece Hungary The Netherlands Poland +1
Previous Page
1 … 5 6 7

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!